Cite
HARVARD Citation
Wittbrodt, E. et al. (2019). Eligibility of patients with type 2 diabetes for sodium‐glucose co‐transporter‐2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry. Diabetes, obesity & metabolism. 21 (8), pp. 1985-1989. [Online].